Merck (MRK) Tops Q4 Views; Reaffirms Outlook
Tweet Send to a Friend
Merck (NYSE: MRK) reports Q4 EPS of $0.87, ex-items, 13 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
